Objective: The purpose of this study was to perform a clinical analysis of nine patients with giant aneurysms managed with endovascular embolization. Methods: From March 2000 to September 2009, nine cases of giant intracranial aneurysms were treated (five unruptured and four ruptured). The nine patients included two males and seven females who were 47 to 72 years old (mean, 59.2 years old). The types of giant intracranial aneurysms were eight internal carotid artery aneurysms and one vertebral artery aneurysm. Treatment for each aneurysm was chosen based on anatomic relationships, aneurysmal factors, and the patients' clinical state. Three patients underwent endovascular coiling with stent and six initially underwent endovascular coiling alone. Medical records, operation records, postoperative angiographies, and follow-up angiographies were reviewed retrospectively. Results: Eight out of nine patients showed good clinical outcomes. (six were excellent and two were good) after a mean follow-up period of 27.9 months. Six (67%) of the nine patients had a near-complete occlusions on the post-operative angiogram (mean, 13.5 months after the procedure). Occlusion rates of 90% or higher were obtained for eight (89%) of all the patients. One patient died due to multiple organ failure. Stents were ultimately required at some point for managing four aneurysms. Two patients needed additional procedures because of aneurysm regrowth. Conclusion: Endovascular treatment could be an alternative option for managing giant aneurysms adjuvant to surgical intervention.
INTRODUCTION
A giant aneurysm is one with the maximal diameter of 25 mm or more in the aneurysmal vessel. This entity represents approximately 5% of all intracranial aneurysm. 9)13)18) Due to the characteristics of giant aneurysms, this type of lesion has poorer prognosis compared to other aneurysms. Moreover, it is associated with high rates of morbidity and mortality.
2)3)5)6)8)9)14)17)21) Many surgical clipping series have morbidity and mortality rates ranging from 26% to 35% and 15% to 21%, respectively. Endovascular treatment should be focused on the complete occlusion, minimum mass effect, preserving the patency of the parent artery, prevention of regrowth, 
RESULTS

Demographics
Data for endovascular treatment of giant aneurysms in nine patients were reviewed. The average age of these patients was 59.2 years. Seven patients were women.
Demographics, presentation, aneurysm size, location, and treatment are summarized in Table 1 . Four ruptured aneurysms presented with subarachnoid hemorrhage (SAH) and five unruptured aneurysms were treated.
Patients in both groups were predominantly female.
There were no significant differences in age or gender between the SAH and non-SAH groups.
Angiographic Outcomes
The last angiogram for the patients in our series was Table 1 .
Illustrative Cases
Patient 3
A 63-year-old woman presented with a decreased level of consciousness, nausea, vomiting, and visual discomfort. 
DISCUSSION
The prognosis of giant aneurysms is very poor because of hemorrhage, mass effect, or thromboembolism.
3)5)21)
Drake et al. 6) reported the natural history of untreatable giant aneurysms. These lesions are associated with a mortality rate of 66% at 2 years and over 80% at 5 years. Because of this, therapeutic strategies should be carefully selected based on lesion locations, morphological features, sizes, and type of associated symptoms.
The transcranial surgical clipping can be a good treatment option if it is feasible. There are several reports of giant aneurysms treated with surgical clipping that produced good results. 9)18) Despite these reports, many neurosurgeons have noted that giant aneurysms are associated with higher surgical morbidity and mortality than small aneurysms, especially when they are located in the posterior circulation. Our series had a few significant limitations.
1) We performed retrospective chart and angiogram reviews. Therefore, we could not eliminate biases inherent of retrospective reviews.
2) Because the occlusion rate in our series was measured using post-operative angiograms, this was probably not the absolute occlusion rate or indicative of stability.
3) Giant aneurysms are not a common aneurysm form.
Thus, we did not experience the sufficient cases with surgical clipping comparable to our cases with endovascular coiling.
4) Because the mean follow-up period in our series was short, there is the possibility that the regrowth rate was underestimated.
5) Due to the small size of our study, we could not rule out the chance that the favorable results were somewhat exaggerated.
The favorable results of our cases do not necessarily mean that endovascular embolization is the treatment of choice for giant aneurysms. However, this technique is one possible treatment option that neurosurgeons should consider when they encounter this type of lesion.
CONCLUSION
Endovascular coil occlusion could be a good adjuvant therapeutic option for treating giant aneurysms. Additionally, strict long-term angiographic follow-up is needed to identify the need for additional therapy in a timely manner.
